Oncology Generic Medicines - Additions

A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")

Source
Find a Tender
Type
Framework (Goods)
Duration
not specified
Value
£155K-£1M
Sector
HEALTH
Published
22 Jun 2021
Delivery
not specified
Deadline
n/a

Concepts

Location

All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014

Geochart for 1 buyers and 11 suppliers

1 buyer

8 suppliers

Description

Supply of oncology generic medicines to NHS Scotland

Lot Division

1 Paclitaxel Albumin Powder for Suspension for Infusion

Supply of paclitaxel albumin powder for suspension for infusion to NHS Scotland. The Authority has awarded this Lot as an unranked multi-supplier framework to two (2) Framework Participants.

Award Criteria
Logistics 5
price 95
2 Everolimus Tablets

Supply of everolimus tablets to NHS Scotland. The Authority has awarded this Lot as a ranked multi-supplier framework to three (3) Framework Participants.

Award Criteria
Logistics 5
price 95
3 Dasatinib Tablets

Supply of dasatinib tablets to NHS Scotland. The Authority has awarded this Lot as a ranked multi-supplier framework to two (2) Framework Participants.

Award Criteria
Logistics 5
price 95
4 Cabazitaxel, Fulvestrant and Vinorelbine

Supply of cabazitaxel, fulvestrant and vinorelbine to NHS Scotland. The Authority has awarded this framework as a single supplier framework per line.

Award Criteria
Logistics 5
price 95
6 Pemetrexed Solution for Infusion

Supply of pemetrexed solution for infusion to NHS Scotland. The Authority has awarded this Lot as a single supplier framework.

Award Criteria
Range of Presentations 15
Extended Stability 10
price 75

Award Detail

1 DR Reddys Laboratories (Beverley)
  • Everolimus Tablets
  • Reference: 014174-2021-1
  • Value: £920,462 [share]
  • Awarded to group of suppliers.
2 Novartis Pharmaceuticals (Frimley)
  • Everolimus Tablets
  • Reference: 014174-2021-1
  • Value: £920,462 [share]
  • Awarded to group of suppliers.
3 Accord Healthcare (North Harrow)
  • Everolimus Tablets
  • Reference: 014174-2021-1
  • Value: £920,462 [share]
  • Awarded to group of suppliers.
4 Zentiva Pharma (London)
  • Dasatinib Tablets
  • Reference: 014174-2021-2
  • Value: £180,844 [share]
  • Awarded to group of suppliers.
5 Tillomed Laboratories (Luton)
  • Dasatinib Tablets
  • Reference: 014174-2021-2
  • Value: £180,844 [share]
  • Awarded to group of suppliers.
6 Accord Healthcare (North Harrow)
  • Pemetrexed Solution for Infusion
  • Reference: 014174-2021-3
  • Value: £154,768
7 DR Reddys Laboratories (Beverley)
  • Cabazitaxel, Fulvestrant and Vinorelbine
  • Reference: 014174-2021-4
  • Value: £1,129,175 [share]
  • Awarded to group of suppliers.
8 Pierre Fabre (Reading)
  • Cabazitaxel, Fulvestrant and Vinorelbine
  • Reference: 014174-2021-4
  • Value: £1,129,175 [share]
  • Awarded to group of suppliers.
9 Teva (Castleford)
  • Cabazitaxel, Fulvestrant and Vinorelbine
  • Reference: 014174-2021-4
  • Value: £1,129,175 [share]
  • Awarded to group of suppliers.
10 Celgene (Uxbridge)
  • Paclitaxel Albumin Powder for Suspension for Infusion
  • Reference: 014174-2021-5
  • Value: £318,078 [share]
  • Awarded to group of suppliers.
11 Teva (Castleford)
  • Paclitaxel Albumin Powder for Suspension for Infusion
  • Reference: 014174-2021-5
  • Value: £318,078 [share]
  • Awarded to group of suppliers.

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated value(s) referred to in Section II.1.7 and within all Lots covers the nineteen (19) month contract duration and the twenty-four (24) month extension period of the framework agreement. For further detail on the award of Lot 4, please contact the named person within Section I of this Notice. (SC Ref:657454)

Reference

Domains